Search results for "Hypersensitivity"

showing 10 items of 364 documents

Improvement in quality of life with omalizumab in patients with severe allergic asthma.

2006

Patients with severe persistent asthma experience daily symptoms and frequent serious exacerbations that contribute to a significant impairment of health-related quality of life (QoL).A pooled analysis was completed of six controlled clinical trials that evaluated the effect of add-on omalizumab on asthma-related QoL in patients with severe persistent allergic (IgE-mediated) asthma. Asthma-related QoL was assessed at baseline and treatment endpoint using the well-validated Juniper Asthma Quality of Life Questionnaire (AQLQ). Change from baseline in AQLQ total score was compared between treatments using analysis of covariance methods. The percentage of patients who achieved a clinically mean…

AdultMalePediatricsmedicine.medical_specialtyAdolescentOmalizumabOmalizumabAntibodies Monoclonal HumanizedSeverity of Illness IndexQuality of lifeSeverity of illnessHypersensitivityMedicineHumansIn patientAnti-Asthmatic AgentsChildAsthmaAgedRandomized Controlled Trials as Topicbusiness.industryAntibodies MonoclonalAllergic asthmaGeneral MedicineMiddle Agedmedicine.diseasehumanitiesAsthmaAntibodies Anti-IdiotypicClinical trialMeta-analysisQuality of LifeFemalebusinessmedicine.drugCurrent medical research and opinion
researchProduct

Airway Responsiveness to Inhaled Acetaldehyde in Subjects with Allergic Rhinitis: Relationship to Methacholine Responsiveness

2002

<i>Background:</i> Asthmatic subjects have an exaggerated airway response to inhaled acetaldehyde, but no information is available on airway responsiveness to this bronchoconstrictor agent in subjects with allergic rhinitis. <i>Objective:</i> The aim of this study was to determine the effect of inhaled acetaldehyde on lung function in nonasthmatic subjects with allergic rhinitis. <i>Methods:</i> A total of 78 adults (43 subjects with allergic rhinitis, 16 asthmatics and 19 healthy subjects) were challenged with increased concentrations of acetaldehyde and methacholine. The response to each bronchoconstrictor agent was measured by the provocative concentra…

AdultMalePulmonary and Respiratory MedicineAllergyBronchoconstrictionAcetaldehydeBronchial Provocation TestsBronchoconstrictor Agentschemistry.chemical_compoundimmune system diseasesHypersensitivitymedicineHumansMethacholine ChlorideRhinitisAsthmaInhalationbusiness.industryAcetaldehyderespiratory systemmedicine.diseaseAsthmarespiratory tract diseasesmedicine.anatomical_structurechemistrySpirometryAnesthesiaFemaleMethacholineBronchial HyperreactivitybusinessAirwayAirway responsivenesscirculatory and respiratory physiologyRespiratory tractmedicine.drugRespiration
researchProduct

Omalizumab in patients with severe persistent allergic asthma in a real-life setting in Germany

2009

Omalizumab is a humanized monoclonal anti-immunoglobulin E (IgE) antibody indicated in Europe for the treatment of uncontrolled severe persistent allergic (IgE-mediated) asthma despite optimal therapy with inhaled corticosteroids and long-acting beta(2) agonists. Between 2005 and 2007 280 patients (58% female, mean age 44+/-16 yrs., 46% on oral corticosteroids, median serum IgE level 235IU/ml) who met the EU criteria for add-on therapy with anti-IgE were treated prospectively with omalizumab by 134 physicians as part of a post-marketing surveillance trial and were followed-up for 6 months. The median follow-up time was 195 days, the patients were treated with a median dose of 450mg omalizum…

AdultMalePulmonary and Respiratory Medicinemedicine.medical_specialtyAllergyAdolescentAllergyOmalizumabOmalizumabAntibodies Monoclonal HumanizedImmunoglobulin ESeverity of Illness IndexYoung AdultQuality of lifeAdrenal Cortex HormonesForced Expiratory VolumeGermanyInternal medicineSeverity of illnessHypersensitivityHumansMedicineAnti-Asthmatic AgentsProspective StudiesChildProspective cohort studyAdverse effectAsthmaDose-Response Relationship Drugbiologybusiness.industryAntibodies MonoclonalMiddle Agedmedicine.diseaseAsthmaAntibodies Anti-IdiotypicSurgeryTreatment Outcomebiology.proteinFemaleIgETherapybusinessmedicine.drugRespiratory Medicine
researchProduct

Cigarette Smoking, But Not Sensitization toAlternaria, Is Associated with Severe Asthma in Urban Patients

2001

Hereditary susceptibility and allergen exposure have been identified as general risk factors for asthma. However, risk factors for severe asthma still remain to be identified. To further assess and quantify risk factors associated with severe asthma in adult patients apart from clinical exacerbations, 306 randomly selected subjects (mean age 40+/-17 years, 46% males) presenting to an inner city pulmonary practice between 1995 and 1996 were retrospectively investigated. Of these, 117 patients were atopic, 112 had current asthma, and 22 asthmatics had severe asthma. Risk factors associated with atopy were family history of atopy and any domestic pet ownership (OR: 3.1, 95% CI: 1.64-6.1). Asth…

AdultMalePulmonary and Respiratory Medicinemedicine.medical_specialtyAllergyUrban Populationmedicine.disease_causeSeverity of Illness IndexAtopyAllergenRisk FactorsForced Expiratory VolumeGermanyInternal medicineImmunopathologyHypersensitivitymedicineHumansImmunology and AllergyFamily historyRisk factorRetrospective StudiesAsthmabusiness.industrySmokingRespiratory diseaseUrban HealthAlternariamedicine.diseaseAsthmarespiratory tract diseasesMultivariate AnalysisPediatrics Perinatology and Child HealthImmunologyFemalebusinessJournal of Asthma
researchProduct

CD4-mediated regulatory T-cell activation inhibits the development of disease in a humanized mouse model of allergic airway disease

2012

Background Based on their potency to control allergic diseases, regulatory T (Treg) cells represent a promising target for novel strategies to interfere with allergic airway inflammation. We have previously demonstrated that stimulation of the CD4 molecule on human Treg cells activates their suppressive activity in vitro and in vivo . Objective We sought to determine the effect of CD4-mediated Treg-cell activation on pulmonary inflammation in a humanized mouse model of allergic airway inflammation. Methods PBMCs obtained from donors allergic to birch pollen or from healthy donors were injected into NOD-severe combined immunodeficiency γc −/− mice, followed by allergen airway challenges and …

AdultMaleRegulatory T cellAHRImmunologychemical and pharmacologic phenomenaInflammationMice SCIDHIV Envelope Protein gp120pulmonary inflammationmedicine.disease_causeT-Lymphocytes Regulatoryregulatory T cellsMiceImmune systemAllergenRespiratory HypersensitivitymedicineAnimalsHumansImmunology and AllergyImmunodeficiencySensitizationSevere combined immunodeficiencybusiness.industryhemic and immune systemsPneumoniaMiddle Agedrespiratory systemmedicine.diseaseRecombinant ProteinsHumanized animal modelrespiratory tract diseasesDisease Models Animalmedicine.anatomical_structureCD4 AntigensImmunologyHumanized mouseLeukocytes MononuclearFemaleInterleukin-4Bronchial Hyperreactivitymedicine.symptombusinessJournal of Allergy and Clinical Immunology
researchProduct

Controlled and uncontrolled allergic asthma in routine respiratory specialist care – a clinical–epidemiological study in Germany

2011

Studies in the last decade showed high rates of poorly treated and poorly controlled asthma in the community. Extending these findings we describe the more recent situation in specialist respiratory care as the most frequent source of treatment provision using comprehensive clinical and patient assessments and exploring predictors for poor control.This is a German cross-sectional, clinical epidemiological study in a nationally representative stratified treatment prevalence sample of N = 572 outpatients diagnosed with allergic asthma (AA; females 58.2%, aged 47.5 ± 16.3 (16-81 years). Treating physicians completed standardized clinical assessments (lung function, laboratory, clinical finding…

AdultMaleRespiratory Therapymedicine.medical_specialtyPediatricsAdolescentCross-sectional studyMEDLINEYoung AdultQuality of lifeGermanyEpidemiologyHypersensitivityPrevalencemedicineHumansPractice Patterns Physicians'Young adultAgedAsthmaAged 80 and overbusiness.industryGeneral MedicineMiddle Agedmedicine.diseaseMental healthAsthmaEpidemiologic StudiesCross-Sectional StudiesFemalebusinessRespiratory careSpecializationCurrent Medical Research and Opinion
researchProduct

Occupational exposure to immunologically active agents and risk for lymphoma: The European Epilymph case-control study

2013

Objectives: Allergies and asthma may be protective for the development of lymphoma. We evaluated whether occupational allergens that provoke immune reactivity and asthma through an IgE-mediated pathway are protective for lymphoma. Methods: The Epilymph study includes histologically or cytologically confirmed Hodgkin, B-cell, and T-cell lymphoma cases from six European countries (Spain, France, Germany, Italy, Ireland, and Czech Republic) recruited in 1998-2004. Controls were frequency matched to cases by age, gender, and study centre. Lifetime occupational exposure to seven high molecular weight (HMW) agents was evaluated through an asthma-specific job-exposure matrix. 2205 lymphoma cases a…

AdultMaleRiskCancer Researchmedicine.medical_specialtyAllergyLymphoma B-CellEpidemiologyHigh molecular weight exposuresLymphoma T-CellImmunoglobulin ELogistic regressionYoung Adultimmune system diseasesInternal medicinehemic and lymphatic diseasesEpidemiologyHypersensitivitymedicineHumansAsthma OccupationalYoung adultAgedAsthmabiologybusiness.industryCase-control studyAllergensImmunoglobulin EMiddle AgedOccupational exposuremedicine.diseaseHodgkin DiseaseLymphomaEuropeMolecular WeightOccupational DiseasesLogistic ModelsOncologyCase-Control StudiesImmunologybiology.proteinFemalebusinessCase–control
researchProduct

The “Mainzer EMF-Wachhund”: results from a watchdog project on self-reported health complaints attributed to exposure to electromagnetic fields

2006

The "Mainzer EMF-Wachhund," a watchdog project, offered a system of self-notification of health complaints attributed to exposures to electromagnetic fields (EMFs) to a population of a part of Germany with about 4 million inhabitants. By using a self-administered questionnaire, which was provided online and for download from the Internet, 192 persons reported such health complaints in the period from October 2003 to March 2005. Of these, 56% classified themselves as electromagnetic hypersensitive (EH). Predictors of this self classification were being affected by all kinds of EMF rather than single EMF sources and being female. On average, EH subjects reported a high degree of suffering, 77…

AdultMaleSelf-Assessmentmedicine.medical_specialtyAdolescentPhysiologyHealth StatusPopulationBiophysicsElectromagnetic hypersensitivityElectromagnetic FieldsGermanySurveys and QuestionnairesmedicineHumansRadiology Nuclear Medicine and imagingChildeducationeducation.field_of_studybusiness.industryInfant NewbornInfantGeneral MedicineMiddle AgedChild PreschoolFamily medicineFemalemedicine.symptombusinessBioelectromagnetics
researchProduct

A comparison between two different in vitro basophil activation tests for gluten- and cow's milk protein sensitivity in irritable bowel syndrome (IBS…

2013

Abstract Background: The diagnosis of food hypersensitivity (FH) in adult patients with gastrointestinal symptoms, beyond the immediate IgE-mediated clinical manifestations, is very often difficult. The aims of our study were to: 1) evaluate the frequency of FH in patients with irritable bowel syndrome (IBS)-like clinical presentation; and 2) compare the diagnostic accuracy of two different methods of in vitro basophil activation tests. Methods: Three hundred and five patients (235 females, age range 18–66 years) were included and underwent a diagnostic elimination diet and successive double-blind placebo-controlled (DBPC) challenges. Two different methods of in vitro basophil activation te…

AdultMaleSettore MED/09 - Medicina InternaAdolescentGlutensClinical Biochemistrygluten-sensitivityIrritable Bowel SyndromeYoung AdultElimination dietMedicineHumansYoung adultIrritable bowel syndromeTriticumWhole bloodAgedchemistry.chemical_classificationCD63business.industryBiochemistry (medical)General MedicineMiddle Agedmedicine.diseaseMilk ProteinsGlutenIn vitroBasophilsBasophil activationCeliac Diseasebasophil activation test; gluten-sensitivity; irritable bowel syndromechemistrybasophil activation testImmunologyFemaleMilk Hypersensitivitybusiness
researchProduct

Relationship Between Human Leucocyte Antigen Class I and Class II and Chronic Idiopathic Urticaria Associated With Aspirin and/or NSAIDs Hypersensiti…

2006

Background. HLA genes play a role in the predisposition of several diseases. The aim was to analyze the prevalence of HLA class I phenotypes and HLA-DRB1*genotype in patients with CIU associated with ASA and NSAIDs hypersensitivity (AICU).Methods. 69 patients with AICU, and 200 healthy subjects.Results. Subjects with HLA-B44 and HLA-Cw5 antigens were more represented in patients with AICU than in control group. Subjects with HLA-A11, HLA-B13, HLACw4, and HLA-Cw7 antigen were more represented in control group than in patients with AICU. Multiple logistic regression demonstrated an association of HLA-Cw4 and HLA-Cw7 with a lower risk of AICU, whereas carriers of HLA-B44 phenotype had a higher…

AdultMaleSettore MED/09 - Medicina InternaChronic Idiopathic UrticariaGenotypeUrticariahuman leucocyte antigen class IImmunologyGenes MHC Class IIAnti-Inflammatory AgentsHuman leukocyte antigenLower riskDrug HypersensitivityResearch CommunicationAntigenGene FrequencyRisk FactorsGenotypelcsh:PathologyMedicineHumansAlleleAllele frequencyAllelesAspirinAspirinbusiness.industryAnti-Inflammatory Agents Non-SteroidalHistocompatibility Antigens Class ICase-control studyCell BiologyHLA-DR AntigensMiddle AgedNSAIDhuman leucocyte antigen class I; human leucocyte antigen class II; chronic idiopathic urticaria; aspirin; NSAIDs; hypersensitivityhuman leucocyte antigen class IIMHC Class IIPhenotypeGenesCase-Control StudiesImmunologyFemalehypersensitivityNon-Steroidalbusinesslcsh:RB1-214medicine.drugHLA-DRB1 ChainsMediators of Inflammation
researchProduct